Effect of lyophilization on liposomal encapsulation of salmon calcitonin
暂无分享,去创建一个
[1] A. Healy,et al. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin. , 2014, Journal of aerosol medicine and pulmonary drug delivery.
[2] A. Healy,et al. In Vitro and In Vivo Characterisation of PEG-Lipid-Based Micellar Complexes of Salmon Calcitonin for Pulmonary Delivery , 2012, Pharmaceutical Research.
[3] R. Prassl,et al. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Dandan Han,et al. An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[5] J. Beijnen,et al. Naked Plasmid DNA Formulation: Effect of Different Disaccharides on Stability after Lyophilisation , 2010, AAPS PharmSciTech.
[6] Vladimir Kral,et al. Therapeutic application of peptides and proteins: parenteral forever? , 2009, Trends in biotechnology.
[7] Yan Liu,et al. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery , 2009, Peptides.
[8] R. Callaghan,et al. The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides. , 2009, Cryobiology.
[9] D. Topgaard,et al. Dynamic and structural aspects of PEGylated liposomes monitored by NMR. , 2008, Journal of colloid and interface science.
[10] M. Olson,et al. Salmon calcitonin: a review of current and future therapeutic indications , 2008, Osteoporosis International.
[11] Laura Zanetti Polzi,et al. Calcitonin forms oligomeric pore-like structures in lipid membranes. , 2006, Biophysical journal.
[12] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[13] S. Onoue,et al. Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration. , 2006, Life sciences.
[14] C. Shim,et al. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[15] Y. Kato,et al. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[16] Yoshinori Kato,et al. In vivo efficacy of a novel double liposome as an oral dosage form of salmon calcitonin , 2003 .
[17] C. Shim,et al. Preparation and evaluation of proliposomes containing salmon calcitonin. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[18] J. Cherng,et al. ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES , 2001, Journal of liposome research.
[19] Schwarz,et al. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). , 1997, International journal of pharmaceutics.
[20] J. Bouwstra,et al. Enhanced permeability of freeze-dried liposomal bilayers upon rehydration. , 1997, Cryobiology.
[21] Wei Zhang,et al. Effect of Freezing Rate on the Stability of Liposomes During Freeze-Drying and Rehydration , 1997, Pharmaceutical Research.
[22] J. Bradshaw. Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin. , 1997, Biophysical journal.
[23] L. Deftos,et al. Liposome entrapment enhances the hypocalcemic action of parenterally administered calcitonin. , 1984, Endocrinology.
[24] B. de Kruijff,et al. Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes. , 1980, Biochimica et biophysica acta.
[25] J C Stewart,et al. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. , 1980, Analytical biochemistry.
[26] C. Stevenson. Advances in peptide pharmaceuticals. , 2009, Current pharmaceutical biotechnology.
[27] Qun Wang,et al. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. , 2008, Journal of drug targeting.
[28] S. Law,et al. Characterization of calcitonin-containing liposome formulations for intranasal delivery. , 2001, Journal of microencapsulation.